We investigated whether spontaneous normalization of negative T waves (TWN) on infarct-related ECG leads (IRLs) in the chronic phase of Q wave anterior myocardial infarction (MI) could be a predictor of residual viability in infarct areas. We prospectively studied 35 patients (age 60 ± 8.6 years) in the chronic phase of Q wave anterior MI. Spontaneous TWN (group A, n = 23) were defined as negative T waves that became upright (≧0.15 mV) in ≧2 IRLs. The presence of negative T waves (group B, n = 12) was defined as symmetric or biphasic negative T wave of ≧0.15 mV. All patients underwent same-day rest 201Tl-stress 99mTc sestamibi dual-isotope myocardial perfusion SPECT and 24-hour 201Tl reinjection imaging for ischemia and viability analysis. On scintigraphic examination, ischemic or viable myocardial segments were found in 18 patients (78%) with TWN and 4 patients (33%) of group B (p = 0.013). The use of TWN as a parameter had a marked influence on the sensitivity (82%), specificity (62%), positive (78%) and negative (67%) predictive values and accuracy (74%) of the diagnosis of viable myocardium. If we add the criterion of positive T waves in aVR with negative T waves to our criteria, we found that sensitivity (90%), positive (80%) and negative (80%) predictive values and accuracy (80%) increased. The results of our study suggest that analysis of TWN on IRLs is an accurate marker of residual viability and/or persistent peri-infarct ischemia in patients in the chronic stage of Q wave anterior MI, and therefore optimizes the diagnostic and therapeutic strategies after MI.

Keywords:
Myocardial infarction, T wave normalization, Scintigraphy, Viability, myocardial
1.
Phibbs B: ‘Transmural’ versus ‘subendocardial’ myocardial infarction: An electrocardiographic myth. J Am Coll Cardiol 1983;1:561–564.
2.
Spodick DH: Q-wave infarction versus S-T infarction. Nonspecificity of electrocardiographic criteria for differentiating transmural and nontransmural lesions. Am J Cardiol 1983;51:913–915.
3.
Maeda S, Imai T, Kuboki K, Chida K, Watanabe C, Ohkawa SI: Pathologic implications of restored positive T waves and persistent negative T waves after Q wave myocardial infarction. J Am Coll Cardiol 1996;28:1514–1518.
4.
Mombilia G, Zanco P, Desideri A, Neri G, Alitto F, Suzzi G, Chierichetti F, Celegon L, Ferlin G, Buchberger R: T wave normalization in infarct-related electrocardiographic leads during exercise testing for detection of residual viability: Comparison with positron emission tomography. J Am Coll Cardiol 1998;32:75–82.
5.
Schneider CA, Helmig AK, Baer FM, Horst M, Erdmann E, Sechtem U: Significance of exercise-induced ST-segment elevation and T-wave pseudonormalization for improvement of function in healed Q-wave myocardial infraction. Am J Cardiol 1998;82:148–153.
6.
Pizzetti G, Montorfano M, Belotti G, Margonato A, Ballarotto C, Chierchia SL: Exercise-induced T-wave normalization predicts recovery of regional contractile function after anterior myocardial infarction. Eur Heart J 1998;19:420–428.
7.
Salustri A, Garyfallidis P, Elhendy A, Ciavatti M, Cornel JH, Gemelli A, ten Cate FJ, Roelandt JRTC, Fioretti PM: T-wave normalization during dobutamine echocardiography for diagnosis of viable myocardium. Am J Cardiol 1995;75:505–507.
8.
Elhendy A, Geleijnse L, Salustri A, van Domburg RT, Cornel JH, Arnese M, Roelandt JRTC, Fioretti PM: T wave normalization during dobutamine stress testing in patients with non-Q wave myocardial infarction. A marker of myocardial ischemia. Eur Heart J 1996;17:526–531.
9.
Cerqueira MD, Weissman NJ, Dilsizian V, Jacobs AK, Kaul S, Laskey WK, Pennell DJ, Rumberger JA, Ryan T, Verani MS; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging: Standardized myocardial segmentation and nomenclature for tomographic imaging of the heart: A statement for healthcare professionals from the Cardiac Imaging Committee of the Council on Clinical Cardiology of the American Heart Association. J Nucl Cardiol 2002;9:240–245.
10.
Durmus-Altun G, Altun A, Yildiz M, Firat MF, Hacimahmutoglu S, Berkarda S, Ozbay G: Irbesartan has a masking effect on dipyridamole stress induced myocardial perfusion defects. Nucl Med Commun 2004;25:195–199.
11.
Tamura A, Nagase K, Mikuriya Y, Nasu M: Significance of spontaneous normalization of negative T waves in infarct-related leads during healing of anterior wall acute myocardial infarction. Am J Cardiol 1999;84:1341–1344.
12.
Nagase K, Tamura A, Mikuriya Y, Nasu M: Spontaneous normalization of negative T wave in infarct-related leads reflects improvement in left ventricular wall motion even in patients with persistent abnormal Q waves after anterior wall acute myocardial infarction. Cardiology 2001;96:94–99.
13.
Sakata K, Yoshino H, Houshaku H, Koide Y, Yotsukura M, Ishikawa K: Myocardial damage and left ventricular dysfunction in patients with and without persistent negative T waves after Q-wave anterior myocardial infarction. Am J Cardiol 2001;87:510–515.
14.
Bosimini E, Giannuzzi P, Temporelli PL, Gentile F, Lucci D, Maggioni AP, Tavazzi L, Badano L, Stoian I, Piazza R, Heyman I, Levantesi G, Cervesato E, Geraci E, Nicolosi GL for the GISSI-3 Echo Substudy Investigators: Electrocardiographic evolutionary changes and left ventricular remodeling after acute myocardial infarction: Results of the GISSI-3 Echo substudy. J Am Coll Cardiol 2000;35:127–135.
15.
Lancellotti P, Gérard PL, Kulbertus HE, Piérard LA: Persistent negative T waves in the infarct-related leads as an independent predictor of poor long-term prognosis after acute myocardial infarction. Am J Cardiol 2002;90:833–837.
16.
Watanabe S, Kawamura Y, Watanabe Y, Tanaka K, Tanaka K, Takei Y, Ejiri N, Shimada K: Viability of Q-wave infarcted myocardium with restored positive and persistent negative T waves after optimal revascularization compared with dobutamine stress echocardiography. Am J Cardiol 2000;85:31–36.
© 2005 S. Karger AG, Basel
2005
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.